Infrastructure Capital Advisors LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 501 shares of the healthcare conglomerate’s stock, valued at approximately $201,000.
A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Jennison Associates LLC raised its stake in UnitedHealth Group by 205.8% during the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock valued at $779,944,000 after acquiring an additional 1,310,783 shares during the last quarter. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 5.8% during the first quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock worth $7,032,097,000 after purchasing an additional 1,040,094 shares during the last quarter. Lazard Asset Management LLC lifted its stake in shares of UnitedHealth Group by 185.4% in the 1st quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock valued at $438,545,000 after purchasing an additional 765,729 shares in the last quarter. Ontario Teachers Pension Plan Board acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $266,424,000. Finally, Geode Capital Management LLC lifted its position in UnitedHealth Group by 4.7% during the 2nd quarter. Geode Capital Management LLC now owns 15,110,522 shares of the healthcare conglomerate’s stock worth $6,033,290,000 after acquiring an additional 679,484 shares in the last quarter. 86.21% of the stock is owned by institutional investors and hedge funds.
In other UnitedHealth Group news, CFO John F. Rex sold 15,438 shares of UnitedHealth Group stock in a transaction on Thursday, July 29th. The shares were sold at an average price of $412.04, for a total value of $6,361,073.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Friday, September 17th. The shares were sold at an average price of $419.00, for a total transaction of $1,047,500.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 101,438 shares of company stock valued at $42,396,929. 0.55% of the stock is currently owned by corporate insiders.
NYSE:UNH traded up $17.53 during trading hours on Thursday, hitting $421.08. 286,393 shares of the stock were exchanged, compared to its average volume of 2,968,564. The company has a market cap of $397.04 billion, a P/E ratio of 28.17, a P/E/G ratio of 1.62 and a beta of 0.77. The firm’s fifty day moving average price is $411.69 and its 200 day moving average price is $405.33. UnitedHealth Group Incorporated has a 52-week low of $299.60 and a 52-week high of $431.36. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping analysts’ consensus estimates of $4.41 by $0.11. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business had revenue of $72.34 billion for the quarter, compared to analyst estimates of $71.24 billion. During the same quarter in the prior year, the company earned $3.51 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 21st. Investors of record on Monday, September 13th were given a $1.45 dividend. The ex-dividend date was Friday, September 10th. This represents a $5.80 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s payout ratio is currently 34.36%.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Article: What is a Call Option?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.